Recent Articles

All product descriptions and articles provided on this website are intended strictly for informational and educational purposes. Our products are designed exclusively for in-vitro research (i.e., experiments conducted outside of a living organism, typically in glassware such as test tubes or petri dishes). These compounds are not approved by the FDA for use in humans or animals. They are not medications, nor are they intended to diagnose, treat, prevent, or cure any disease or medical condition. Any bodily administration-human or animal-is strictly prohibited by law. Our products are not for human consumption under any circumstances.

Diagram showing Retatrutide’s multi-receptor actions improving lipid metabolism and cardiovascular health.

What Role Does Retatrutide Play in Advancing At...

Explore how Retatrutide, a multi-receptor peptide, influences lipid metabolism and cardiovascular research through scientific, evidence-based mechanisms. This blog highlights its metabolic impact, clinical findings, and future research directions while maintaining a professional research focus. Discover how Peptidic supports advanced peptide studies with precision, transparency, and high-quality research-grade compounds for metabolic and cardiovascular investigations.

 

Posted in: News

read more
 Illustration showing KLOW peptides’ role in energy metabolism, lipid oxidation, and glucose utilization.

How Research Links KLOW Peptide to Energy and M...

KLOW peptides play a vital role in exploring cellular energy metabolism and mitochondrial function. This blog discusses how they regulate biochemical pathways and influence energy production in research environments. It reviews preclinical findings and molecular mechanisms in controlled settings. Supported by Peptidic’s research-grade peptide solutions, these insights advance precision-driven metabolic research and scientific innovation.

 

Posted in: News

read more
Visual explaining dual GIP/GLP-1 agonists enhancing metabolic outcomes and supporting personalized future therapies.

What evidence supports tirzepatide as an effect...

This article explores how investigational incretin-based peptides, such as Tirzepatide, are advancing metabolic research through controlled experimental and translational models. It highlights glycemic endpoints, receptor-signaling mechanisms, reproducibility requirements, and data integrity standards. Moreover, the content emphasizes scientifically neutral evaluation without promoting human therapeutic use, supporting researchers seeking reliable, high-purity peptide materials for ongoing metabolic investigations.

 

Posted in: News

read more
Infographic showing Cagrilintide’s multi-pathway stroke defense through metabolic, vascular, and neuroprotection.

Does Scientific Research Support Cagrilintide’s...

Explore how Cagrilintide supports stroke prevention and cardiovascular research through metabolic regulation and vascular protection. Learn about its mechanisms, ongoing clinical trials, and comparison with other antidiabetic agents. Discover how Peptidic’s high-purity research peptides empower scientists with consistent, reliable results for metabolic and cerebrovascular studies, advancing global innovation in peptide-based cardiovascular and stroke research.

 

 

Posted in: News

read more
Diagram showing GLP-1 receptor pathways regulating lipid metabolism, oxidation, and cholesterol efflux.

Can GLP-1 Pathways Help Regulate Lipid Metaboli...

This blog explains how GLP-1 pathways play a crucial role in regulating lipid metabolism and maintaining vascular health. It examines their impact on fatty acid oxidation, triglyceride synthesis, and cholesterol efflux. The discussion highlights how GLP-1 signaling combats atherogenic dyslipidemia. Together, these insights reveal their importance in improving lipid balance and cardiovascular outcomes.

Posted in: News

read more
Infographic image showing how AOD 9604 enhances diabetic wound healing through cellular repair.

Can AOD Accelerate Healing in Diabetic Foot Ulc...

Discover how AOD 9604, a synthetic peptide fragment of human growth hormone, is being studied for its potential role in diabetic wound research. Scientific investigations have explored its effects on collagen synthesis, cellular signaling, and tissue regeneration under controlled laboratory conditions. At Peptidic, we focus on advancing peptide science by providing research-grade AOD9604 for experimental use, supporting ongoing studies that aim to deepen the understanding of peptide-based mechanisms in diabetic wound healing.

 

 

Posted in: News

read more